Geographic Expansion Khiron operates in Latin America and Europe with sales in Colombia, Peru, Germany, UK, and Brazil, and plans to commence sales in Mexico. This presents cross-border sales opportunities for medical cannabis products, telemedicine services, and clinic partnerships in emerging markets with evolving regulatory frameworks.

Integrated Clinics Owns medical health clinics and telemedicine platforms, enabling direct patient access, education programs, and prescription conversion. Leverage partnerships with clinics and telemedicine channels to upsell new formulations, services, or education-driven campaigns to clinicians and patients.

European Distribution EU-GMP distribution hub in Germany supports product portfolio expansion into Germany, UK, and Switzerland. Target European distributors, pharmacies, and clinics to broaden reach and accelerate regulatory-compliant product uptake across multiple markets.

Financial Readiness Recent financing and loan activity, plus leadership changes in finance, indicate ongoing liquidity and governance adjustments. This creates opportunities to present scalable commercial collaborations, co-funded pilots, and performance-based distribution deals aligned with funding timelines.

Strategic Partnerships Past and ongoing partnerships (e.g., Skyecast) and a focus on physician education programs offer avenues for channel partnerships, software integrations, and joint healthcare initiatives to expand patient engagement and prescription generation.